Fragile X Syndrome - Executive Insights - Fragile X Syndrome | Executive Insights | US/EU5/China
Fragile X Syndrome | Executive Insights | US/EU5/China | 2021
Kristine Mackin, Ph.D.
Kristine Mackin, Ph.D., is a director on the Immune and Inflammatory Disorders team at Clarivate. Her expertise includes emerging microbiome-based therapies, psoriatic arthritis, chronic obstructive pulmonary disease, and asthma. Previously, Dr. Mackin was involved with a new company pitch focusing on the infant microbiome, now realized as Commense, during an internship at Puretech Ventures in Boston. She holds a doctorate in biochemistry from Brandeis University, where she studied the evolution of bacteriorhodopsin and the relationship between type I and type II rhodopsins.